More tools:Markets·Screener·Research·Chat

Roivant Sciences Ltd. Common Shares (ROIV) Financial Statements

Roivant Sciences Ltd. Common Shares
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG007STW2C7
XNAS · usd
35.40▲ 0.15 (0.43%)
As of 2026-08-12
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)$8.3M
Net Income (TTM)-$299.8M
EBITDA
Diluted EPS (TTM)
EBITDA Margin-6195.2%
Net Debt
Trading Information
Previous Close35.25
Day's Range34.56 – 36.00
52-Week Range10.90 – 37.00
Volume5.8M
Avg Volume5.1M
Share Statistics
Shares Outstanding719.3M
Employees750
ExchangeXNAS
Listed2021-10-01

No financial data found for ROIV

Try a different ticker. We may not have processed this company's filings yet.

Key questions about Roivant Sciences Ltd. Common Shares (ROIV)
What is Roivant Sciences Ltd. Common Shares's Market Cap?
Roivant Sciences Ltd. Common Shares's Market Cap is $25.5B, based on as-reported figures from SEC (XBRL) filings.
What is Roivant Sciences Ltd. Common Shares's Enterprise Value?
Roivant Sciences Ltd. Common Shares's Enterprise Value is $21.1B, based on as-reported figures from SEC (XBRL) filings.
What is Roivant Sciences Ltd. Common Shares's Price / Sales?
Roivant Sciences Ltd. Common Shares's Price / Sales is 3082.6×, based on as-reported figures from SEC (XBRL) filings.
What is Roivant Sciences Ltd. Common Shares's EV / Revenue?
Roivant Sciences Ltd. Common Shares's EV / Revenue is 2554.6×, based on as-reported figures from SEC (XBRL) filings.
What is Roivant Sciences Ltd. Common Shares's EV / EBITDA?
Roivant Sciences Ltd. Common Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Roivant Sciences Ltd. Common Shares's Revenue (TTM)?
Roivant Sciences Ltd. Common Shares's Revenue (TTM) is $8.3M, based on as-reported figures from SEC (XBRL) filings.
What is Roivant Sciences Ltd. Common Shares's Net Income (TTM)?
Roivant Sciences Ltd. Common Shares's Net Income (TTM) is -$299.8M, based on as-reported figures from SEC (XBRL) filings.
What is Roivant Sciences Ltd. Common Shares's EBITDA?
Roivant Sciences Ltd. Common Shares's EBITDA is -$511.7M, based on as-reported figures from SEC (XBRL) filings.
What is Roivant Sciences Ltd. Common Shares's Diluted EPS (TTM)?
Roivant Sciences Ltd. Common Shares's Diluted EPS (TTM) is -0.42, based on as-reported figures from SEC (XBRL) filings.
What is Roivant Sciences Ltd. Common Shares's EBITDA Margin?
Roivant Sciences Ltd. Common Shares's EBITDA Margin is -6195.2%, based on as-reported figures from SEC (XBRL) filings.